New H. Pylori Treatment? Bowel Urgency in IBD; Liver Cancer and MASLD

By News Health
4 hours Ago

(MedPage Today) — In a phase III trial from China, triple therapy containing rifasutenizol — a novel antimicrobial designed for Helicobacter pylori — proved noninferior to bismuth plus clarithromycin-based triple therapy in the first-line…

Source link : https://www.medpagetoday.com/gastroenterology/generalgastroenterology/117423

Author :

Publish date : 2025-09-11 19:33:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

GLP-1 Drugs Reduce Rheumatoid Arthritis Symptoms, Study Suggests

FTC's Change of Heart on Noncompetes Draws Mixed Reviews

Ebola Cases Rise as Authorities Race to Contain Congo Outbreak, Health Agency Says

Dr. Pepper vs RFK Jr.; 'Not How Science Works'; Which Health Policy Are You?

First Child Dosed in Gene Therapy Trial Dies

U.S. May Not Be Ready for the Next Outbreak, Ex CDC Official Says